A phase 2 liver trial where the add-on drug didn't help — and the base drug quietly did
Read the Sunday Brief →

Study wrapper · #362

Effects of Geroprotectors on Age-Related Changes in Proteolytic Digestive Enzyme Activities at Different Lighting Conditions.

Morozov AV, Khizhkin EA, Svechkina EB, et al. Bulletin of experimental biology and medicine. 2015.
Weak / noneAnimal (in vivo)Mentions: Epitalon

Editor's note

In a rat study, researchers examined how the pineal peptide epithalon (epitalon) and melatonin affected age-related changes in digestive-enzyme activity under different lighting conditions. They reported that constant or natural (irregular) lighting disturbed the normal age pattern of pepsin and total proteolytic activity in the stomach and pancreas, and that giving melatonin or epithalon to constant-light animals partly restored the age dynamics of pepsin activity while having little effect on total proteolytic activity. This is a preclinical in-vivo study with a narrow, mechanistic endpoint (enzyme activity), not a clinical outcome. The finding is modest and selective — pepsin dynamics shifted, broader proteolytic activity did not. It fits epitalon's recurring research theme of circadian and pineal modulation, but the whole line of work comes largely from one institutional lineage with limited independent replication. Read this as a mechanistic signal in rodents; human data are needed before clinical conclusions can be drawn.

Plain-language abstract

Researchers studied rats to see how two pineal-gland substances — melatonin and epithalon (epitalon) — affected the activity of protein-digesting enzymes in the stomach and pancreas as the animals aged, and how different lighting affected this. Normally, the activity of these enzymes rose until about 12 months of age and then fell. When rats were kept under constant light or irregular natural light, this normal age-related pattern was disrupted. Giving melatonin or epithalon to rats kept under constant light restored the normal age-related pattern of pepsin (a stomach enzyme) activity, but had little effect on overall protein-digesting activity. The study measured enzyme activity in animals only; it did not test people and reported no clinical outcomes or side effects. Because this was done in rats, it cannot tell us what epitalon would do in humans.